Stem cell marker expression and proliferation and apoptosis of vascular smooth muscle cells

Cell Cycle

Volumn 7, Issue 24, 2008, Pages 3889-3897

  Orlandi, Augusto ^a   Di Lascio, Antonio ^a   Francesconi, Arianna ^a   Scioli, Maria Giovanna ^a   Arcuri, Gaetano ^a   Ferlosio, Amedeo ^a   Spagnoli, Luigi Giusto ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Alpha smooth muscle actin; Apoptosis; Cell heterogeneity; Flt 1; Stem cell markers; Vascular remodelling

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD133 ANTIGEN; STEM CELL FACTOR; VASCULOTROPIN RECEPTOR 1;

ANIMAL CELL; ANIMAL TISSUE; AORTA INJURY; APOPTOSIS; ARTICLE; CELL HETEROGENEITY; CELL PROLIFERATION; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; STEM CELL; VASCULAR SMOOTH MUSCLE;

RATTUS;

EID: 58049196724     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.7.24.7323     Document Type: Article

References (40)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362:801-9.
2. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury I. Smooth muscle growth in the absence of endothelium. Lab Invest 1983; 49:327-33.
3. Gabbiani G, Kocher O, Bloom WS, Vandekerckhove J, Weber K. Actin expression in smooth muscle cells of rat aortic intimal thickening, human atheromatous plaque and cultured rat aortic media. J Clin Invest 1984; 73:148-52.
4. Orlandi A, Ehrlich HP, Ropraz P, Spagnoli LG, Gabbiani G. Rat aortic smooth muscle cells isolated from different layers and at different times after endothelial denudation show distinct biological features in vitro. Arterioscler Thromb 1994; 14:982-9.
5. Clowes A, Reidy M, Clowes M. Mechanisms of stenosis after arterial injury. Lab Invest 1983; 49:208-15.
6. Benditt EP, Benditt JM. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci USA 1973; 70:1753-6.
7. Hirschi KK, Majesky MW. Smooth muscle stem cells. Anat Rec A Discov Mol Cell Evol Biol 2004; 276:22-33.
8. Bochaton-Piallat ML, Gabbiani F, Redard M, Desmouliere A, Gabbiani G. Apoptosis participates in cellularity regulation during rat aortic intimal thickening. Am J Pathol 1995; 146:1059-64.
9. Isner JM, Kearney M, Bortman S, Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation 1995; 91:2703-11.
10. Orlandi A, Francesconi A, Cocchia D, Corsini A, Spagnoli LG. Phenotypic heterogeneity influences apoptotic susceptibility to retinoic acid and cis-platinum of rat arterial smooth muscle cells in vitro: Implications for the evolution of experimental intimal thickening. Arterioscler Thromb Vasc Biol 2001; 21:1118-23.
11. Hao H, Gabbiani G, Bochaton-Piallat ML. Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development. Arterioscler Thromb Vasc Biol 2003; 23:1510-20.
12. Hibbert B, Chen YX, O'Brien ER. c-kit-immunopositive vascular progenitor cells populate human coronary in-stent restenosis but not primary atherosclerotic lesions. Am J Physiol Heart Circ Physiol 2004; 287:518-24.
13. Torsney E, Mandal K, Halliday A, Jahangiri M, Xu Q. Characterisation of progenitor cells in human atherosclerotic vessels. Atherosclerosis 2007; 191:259-64.
14. Zhao Q, Egashira K, Hiasa K, Ishibashi M, Inoue S, Ohtani K, et al. Essential role of vascular endothelial growth factor and Flt-1 signals in neointimal formation after periadventitial injury. Arterioscler Thromb Vasc Biol 2004; 24:2284-9.
15. Ikuta K, Ingolia DE, Friedman J, Heimfeld S, Weissman IL. Mouse hematopoietic stem cells and the interaction of c-kit receptor and steel factor. Int J Cell Cloning 1991; 9:451-60.
16. Hristov M, Weber C. Endothelial progenitor cells: characterization, pathophysiology and possible clinical relevance. J Cell Mol Med 2004; 8:498-508.
17. De Falco S, Gigante B, Persico MG. Structure and function of placental growth factor. Trends Cardiovasc Med 2002; 12:241-6.
18. Luttun A, Tjwa M, Moons L, Wu Y, Angelillo-Scherrer A, Liao F, et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med 2002; 8:831-40.
19. Hu Y, Davison F, Ludewig B, Erdel M, Mayr M, Url M, et al. Smooth muscle cells in transplant atherosclerotic lesions are originated from recipients, but not bone marrow progenitor cells. Circulation 2002; 106:1834-9.
20. Bentzon JF, Weile C, Sondergaard CS, Hindkjaer J, Kassem M, Falk E. Smooth muscle cells in atherosclerosis originate from the local vessel wall and not circulating progenitor cells in ApoE knockout mice. Arterioscler Thromb Vasc Biol 2006; 26:2696-702.
21. Bentzon JF, Sondergaard CS, Kassem M, Falk E. Smooth muscle cells healing atherosclerotic plaque disruptions are of local, not blood, origin in apolipoprotein E knockout mice. Circulation 2007; 116:2053-61.
22. Wang CH, Verma S, Hsieh IC, Hung A, Cheng TT, Wang SY, et al. Stem cell factor attenuates vascular smooth muscle apoptosis and increases intimal hyperplasia after vascular injury. Arterioscler Thromb Vasc Biol 2007; 27:540-7.
23. Bochaton-Piallat ML, Ropraz P, Gabbiani F, Gabbiani G. Phenotypic heterogeneity of rat arterial smooth muscle cell clones. Implications for the development of experimental intimal thickening. Arterioscler Thromb Vasc Biol 1996; 16:815-20.
24. Orlandi A, Francesconi A, Marcellini M, Di Lascio A, Spagnoli LG. Propionyl-L-carnitine reduces proliferation and potentiates Bax-related apoptosis of aortic intimal smooth muscle cells by modulating nuclear factor-kappaB activity. J Biol Chem 2007; 282:4932-42.
25. Erl W, Hansson GK, de Martin R, Draude G, Weber KS, Weber C. Nuclear factor-kappaB regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells. Circ Res 1999; 84:668-77.
26. Frid MG, Aldashev AA, Nemenoff RA, Higashito R, Westcott JY, Stenmark KR. Subendothelial cells from normal bovine arteries exhibit autonomous growth and constitutively activated intracellular signaling. Arterioscler Thromb Vasc Biol 1999; 19:2884-93.
27. Holifield B, Helgason T, Jemelka S, Taylor A, Navran S, Allen J, et al. Differentiated vascular myocytes: are they involved in neointimal formation? J Clin Invest 1996; 97:814-25.
28. Sainz J, Al Haj Zen A, Caligiuri G, Demerens C, Urbain D, Lemitre M, et al. Isolation of "side population" progenitor cells from healthy arteries of adult mice. Arterioscler Thromb Vasc Biol 2006; 26:281-6.
29. Brisset AC, Hao H, Camenzind E, Bacchetta M, Geinoz A, Sanchez JC, et al. Intimal smooth muscle cells of porcine and human coronary artery express S100A4, a marker of the rhomboid phenotype in vitro. Circ Res 2007; 100:1055-62.
30. Orlandi A, Ferlosio A, Gabbiani G, Spagnoli LG, Ehrlich PH. Phenotypic heterogeneity influences the behavior of rat aortic smooth muscle cells in collagen lattice. Exp Cell Res 2005; 311:317-27.
31. Cai J, Ahmad S, Jiang WG, Huang J, Kontos CD, Boulton M, et al. Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells. Diabetes 2003; 52:2959-68.
32. Thanos D, Maniatis T. NFkappaB: a lesson in family values. Cell 1995; 80:529-32.
33. Lindner V. The NFkappaB and IkappaB system in injured arteries. Pathobiology 1998; 66:311-20.
34. Roy H, Bhardwaj S, Babu M, Kokina I, Uotila S, Ahtialansaari T, et al. VEGF-A, VEGF-D, VEGF receptor-1, VEGF receptor-2, NFkappaB and RAGE in atherosclerotic lesions of diabetic Watanabe heritable hyperlipidemic rabbits. Faseb J 2006; 20:2159-61.
35. Bourcier T, Sukhova G, Libby P. The nuclear factor kappa-B signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis. J Biol Chem 1997; 272:15817-24.
36. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS Jr. NFkappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998; 281:1680-3.
37. Deveraux QL, Reed JC. IAP family proteins - suppressors of apoptosis. Genes Dev 1999; 13:239-52.
38. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74:609-19.
39. Orlandi A, Marcellini M, Pesce D, Calvani M, Spagnoli LG. Propionyl-L-carnitine reduces intimal hyperplasia after injury in normocholesterolemic rabbit carotid artery by modulating proliferation and caspase 3-dependent apoptosis of vascular smooth muscle cells. Atherosclerosis 2002; 160:81-9.
40. Toruner M, Fernandez-Zapico M, Sha JJ, Pham L, Urrutia R, Egan LJ. Antianoikis effect of nuclear factor-kappaB through upregulated expression of osteoprotegerin, BCL-2 and IAP-1. J Biol Chem 2006; 281:8686-96.